Summary
The adult respiratory distress syndrome (ARDS) is characterized by extended inflammatory processes in the lung microvascular, interstitial, and alveolar compartments, resulting in vasomotor disturbances, plasma leakage, cell injury, and complex gas exchange disturbances. Abnormalities in the alveolar surfactant system have long been implicated in the pathogenetic sequelae of this life-threatening syndrome. This hypothesis is supported by similarities in pulmonary failure between patients with ARDS and preterm babies with infant respiratory distress syndrome, known to be triggered primarily by lack of surfactant material. Mechanisms of surfactant alterations in ARDS include: (a) lack of surface-active compounds (phospholipids, apoproteins) due to reduced generation/release by diseased pneumocytes or to increased loss of material (this feature includes changes in the relative composition of the surfactant phospholipid and/or apoprotein profiles); (b) inhibition of surfactant function by plasma protein leakage (inhibitory potencies of different plasma proteins have been defined); (c) “incorporation” of surfactant phospholipids and apoproteins into polymerizing fibrin upon hyaline membrane formation; and (d) damage/inhibition of surfactant compounds by inflammatory mediators (proteases, oxidants, nonsurfactant lipids). Alterations in alveolar surfactant function may well contribute to a variety of pathophysiological key events encountered in ARDS. These include decrease in compliance, ventilation-perfusion mismatch including shunt flow due to altered gas flow distribution (atelectasis, partial alveolar collapse, small airway collapse), and lung edema formation. Moreover, more speculative at the present time, surfactant abnormalities may add to a reduction in alveolar host defense competence and an upregulation of inflammatory events under conditions of ARDS. Persistent atelectasis of surfactant-deficient and in particular fibrin-loaded alveoli may represent a key event to trigger fibroblast proliferation and fibrosis in late ARDS (“collapse induration”). Overall, the presently available data on surfactant abnormalities in ARDS lend credit to therapeutic trials with transbronchial surfactant administration. In addition to the classical goals of replacement therapy defined for preterm infants (rapid improvement in lung compliance and gas exchange), this approach will have to consider its impact on host defense competence and inflammatory and proliferative processes when applied in adults with respiratory failure.
Article PDF
Similar content being viewed by others
Abbreviations
- ARDS:
-
adult respiratory distress syndrome
- IRDS:
-
infant respiratory distrss syndrome
- PC:
-
phosphatidylcholine
- PG:
-
phosphatidylglycerol
- PE:
-
phosphatidylethanolamine
- PS:
-
phosphatidylserine
- PI:
-
phosphatidylinositol
- Sph:
-
spingomyelin
- BAL:
-
bronchoalveolar lavage
- TNF:
-
tumor necrosis factor
References
Albert RK, Lakshminarayan S, Hildebrandt J, Kirk W (1979) Increased surface tension favours pulmonary edema formation in anaesthetized dogs' lungs. J Clin Invest 63:1015–1018
Allen JN, Herzyk DJ, Wewers MD (1992) Surfactant suppresses interleukin-1 β and tumor necrosis factor-α release by human alveolar macrophages. Am Rev Respir Dis 145:A875
Ansfield MJ, Benson BJ (1980) Identification of the immunosuppressive components of canine pulmonary surface active material. J Immunol 125:1093–1098
Ansfield MJ, Kaltreider HB, Benson BJ, Caldwell JL (1980) Immunosuppressive activity of canine pulmonary surface active material. J Immunol 122:1062–1066
Ansfield MJ, Kaltreider HB, Benson NJ, Shalaby MR (1980) Canine surface active material and pulmonary lymphocyte function studies with mixed-lymphocyte culture. Exp Lung Res 1:3–11
Bachofen M, Weibel EF (1982) Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin Chest Med 3:35–56
Balis JU, Shelley SA, McCue MJ, Rappaport ES (1971) Mechanisms of damage to the lung surfactant system. Ultrastructure and quantitation of normal and in vitro inactivated lung surfactant. Exp Mol Pathol 14:243–262
Berggren P, Lachmann B, Curstedt T, Grossmann G, Robertson B (1986) Gas exchange and lung morphology after surfactant replacement in experimental adult respiratory distress syndrome induced by repeated lung lavage. Acta Anaesthesiol Scand 30:321–328
Berry D, Ikegami M, Jobe A (1986) Respiratory distress and surfactant inhibition following vagotomy in rabbits. J Appl Physiol 61:1741–1748
Bertozzi P, Astedt B, Zenzius L, Lynch K, LeMaire F, Zapol W, Chapman H (1990) Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med 322:890–897
Bredenberg CE, Paskanik AM, Nieman GF (1983) High surface tension pulmonary edema. J Surg Res 34:515–523
Burkhardt A (1989) Alveolitis and collapse in the pathogenesis of pulmonary fibrosis. Am Rev Respir Dis 140:513–524
Chapman HA, Allen CL, Stone L (1986) Abnormalities in pathways of alveolar fibrin turnover among patients with interstitiell lung disease. Am Rev Respir Dis 133:437–443
Chapman HA, Reilly JJ, Kobzik L (1988) Role of plasminogen activator in degradation of extracellular matrix protein by live human alveolar macrophages. Am Rev Respir Dis 137:412–419
Chapman HA, Bertozzi P, Sailor LZ, Nusrat AR (1990) Alveolar macrophage urokinase receptors localize enzyme activity to the cell surface. Am J Physiol 259:L432-L438
Christner P, Fein A, Goldberg S, Lippmann M, Abrams W, Weinbaum G (1985) Collagenase in the lower respiratory tract of patients with adult respiratory distress syndrome. Am Rev Respir Dis 131:690–695
Cochrane CG, Spragg R, Revak SD (1983) Pathogenesis of the adult respiratory distress syndrome. J Clin Invest 71:754–761
Cockshutt AM, Possmayer F (1991) Lysophosphatidylcholine sensitizes lipid extracts of pulmonary surfactant to inhibition by serum proteins. Biochim Biophys Acta 1086:63–71
Cockshutt AM, Weitz J, Possmayer F (1990) Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry 29:8424–8429
Coonrod JD, Yoneda K (1981) Detection and partial characterization of antibacterial factor(s) in alveolar lining material of rats. J Clin Invest 71:129–141
Coonrod JD, Lester RL, Chi Hsu L (1984) Characterization of the extracellular bactericidal factors of rat alveolar lining material. J Clin Invest 74:1269–1279
Collaborative European Multicenter Study Group (1988) Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Pediatrics 82:683–691
Crouch E, Rust K, Marienchek W, Parghi D, Chang D, Persson A (1991) Developmental expression of pulmonary surfactant protein D (SP-D). Am J Respir Cell Mol Biol 5:13–18
Egan EA, Notter RN, Kwong MS, Shapiro DL (1983) Natural and artificial lung surfactant replacement therapy in premature lambs. J Appl Physiol 55:875–883
Evander E, Wollmer P, Jonson B, Lachmann B (1987) Pulmonary clearance of inhaled 99mTc-DTPA: effects of surfactant depletion by lung lavage. J Appl Physiol 62:1611–1614
Froh D, Ballard PL, Williams MC, Gonzales J, Goerke J, Odom MW, Gonzales LW (1990) Lamellar bodies of cultured human fetal lung: content of surfactant protein A (SP-A), surface film formation and structural transformation in vitro. Biochim Biophys Acta 1052:78–89
Fuchimukai T, Fuchiwara T, Takahashi A, Enhorning G (1987) Artificial pulmonary surfactant inhibited by proteins. J Appl Physiol 62:429–437
Goerke J, Clements JA (1986) Alveolar surface tension and lung surfactant. In: Macklem PT, Mead J (eds) Handbook of physiology, American Physiological Society, Bethesda, pp 247–261
Gregory TJ, Longmore WJ, Moxlcy MA, Whitsett JA, Reed CR, Fowler AA, Hudson LD, Maunder RJ, Crim C, Hyers TM (1991) Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 88:1976–1981
Grimminger F, Becker G, Seeger W (1988) High yield enzymatic conversion of intravascular leukotriene A4 in blood-free perfused lungs. J Immunol 141:2431–2436
Grimminger F, Menger M, Becker G, Seeger W (1988) Potentiation of leukotriene generation following sequestration of neutrophils in isolated lungs. Blood 72:1687–1692
Grimminger F, Kreusler B, Schneider U, Becker G, Seeger W (1990) Influence of microvascular adherence on neutrophil leukotriene generation - evidence for cooperative eicosanoid synthesis. J Immunol 144:1866–1872
Grimminger F, Kreusler B, Schneider U, von Witzleben E, Walmrath D, Neppert J, Seeger W (1991) Human leukoagglutinating antibody evokes cooperative leukotriene synthesis in pulmonary microvasculature - model of transfusion-related acute lung injury (TRALI). Circ Res 68:503–512
Grimminger F, Sibelius U, Seeger W (1991) Amplification of LTB4 generation in AM-PMN cocultures: transcellular 5-lipoxygenase metabolism. Am J Physiol 261:L195-L203
Grimminger F, von Kürten I, Walmrath D, Seeger W (1992) Type II alveolar epithelial eicosanoid metabolism — predominance of cyclooxygenase pathways, and transcellular lipoxygenase metabolism in co-culture with neutrophils. Am J Respir Cell Mol Biol 6:9–16
Gross TJ, Simon RH, Sitrin RG (1992) Tissue factor procoagulant expression by rat alveolar epithelial cells. Am J Respir Cell Mol Biol 6:397–403
Hall SB, Venkitaraman AR, Whitsett JA, Holm BA, Notter RH (1992) Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants. Am Rev Respir Dis 145:24–30
Hallman M (1991) Lung surfactant in respiratory distress syndrome. Acta Anaesthesiol Scand 35 [Suppl 95]:15–21
Hallman M, Spragg R, Harrell JH, Moser KM, Gluck L (1982) Evidence of lung surfactant abnormality in respiratory failure. J Clin Invest 70:673–683
Hallman M, Maasilta P, Kivisaari L, Mattson K (1990) Changes in surfactant in bronchoalveolar lavage fluid after hemithorax irradiation in patients with mesothelioma. Am Rev Respir Dis 141:998–1005
Hamm H, Fabel H, Bartsch W (1992) The surfactant system of the adult lung: physiology and clinical perspectives. Clin Investig 70:637–657
Hawwood JL (1987) Lung surfactant. Prog Lipid Res 26:211–256
Hasday JD, Bachwich PR, Lynch JP, Sitrin RG (1988) Procoagulant and plasminogen activator activities of bronchoalveolar fluid in patients with pulmonary sarcoidosis. Exp Lung Res 14:261–278
Hasleton PS (1983) Adult respiratory distress syndrome: a review. Histopathology 7:037–332
Hasleton PS (1983) The lung parenchyma in burns. Histopathology 7:333–347
Hawgood S (1989) Pulmonary surfactant apoproteins: a review of protein and genomic structure. Am J Physiol 257:L13-L22
Hawgood S, Benson BJ, Schilling J, Damm D, Clements JA, White RT (1987) Nucleotide and amino acid sequences of pulmonary surfactant protein SP 18 and evidence for cooperation between SP 18 and SP 28–36 in surfactant lipid adsorption. Proc Natl Acad Sci USA 84:66–70
Hayakawa H, Myrvik QN, St. Clair RW (1989) Pulmonary surfactant inhibits priming of rabbit alveolar macrophages. Am Rev Respir Dis 140:1390–1397
Hennes HM, Lee MB, Rimm AA, Shapiro DL (1991) Surfactant replacement therapy in respiratory distress syndrome. Am J Dis Child 145:102–104
Holm BA, Notter RH (1987) Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity. J Appl Physiol 63:1434–1442
Holm BA, Notter RH, Finkelstein JN (1985) Surface property changes from interactions of albumin with natural lung surfactant and extracted lung lipids. Chem Phys Lipids 38:287–298
Holm BA, Venkitaraman AR, Enhorning G, Notter RH (1990) Biophysical inhibition of synthetic lung surfactants. Chem Phys Lipids 52:243–250
Holm BA, Keicher L, Liu M, Sokolowski J, Enhorning G (1991) Inhibition of pulmonary surfactant function by phospholipases. J Appl Physiol 71:317–321
Huang YC, Fawcett TA, Moon RE, Fracia PJ, Simonson SG, Sane AC, Piantadosi CA, Young SL (1992) Exogenous surfactant treatment improves VA/Q abnormalities in hyperoxic lung injury. Am Rev Respir Dis 145:A609
Idell S, Gonzalez KK, Bradford H, MacArthur CK, Fein AM, Maunder RJ, Garcia JGN, Griffith DE, Weiland J, Martin TR, McLarty J, Fair DS, Walsh PN, Colman RW (1987) Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Am Rev Respir Dis 136:1466–1474
Idell S, Gonzalez KK, MacArthur CK, Gillies C, Walsh PN, McLarty J, Thrall RS (1987) Bronchoalveolar lavage procoagulant activity in bleomycin induced lung injury in marmosets. Am Rev Respir Dis 136:124–133
Idell S, Peterson BT, Gonzalez KK, Gray LD, Bach R, McLarty J, Fair DS (1988) Local abnormalities of coagulation and fibrinolysis and alveolar fibrin deposition in sheep with oleic acid-induced lung injury. Am Rev Respir Dis 138:1282–1294
Idell S, James KK, Gillies C, Fair DS, Thrall RS (1989) Abnormalities of pathways of fibrin turnover in lung lavage of rats with oleic acid and bleomycin-induced lung injury support alveolar fibrin deposition. Am J Pathol 135:387–399
Idell S, James KK, Levin EG, Schwartz BS, Manchanda N, Maunder RJ, Martin TR, McLarty J, Fair DS (1989) Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 84:695–705
Idell S, Peters J, James KK, Fair DS, Coalson JJ (1989) Local abnormalities of coagulation and fibrinolytic pathways that promote alveolar fibrin deposition in the lungs of baboons with diffuse alveolar damage. J Clin Invest 84:181–193
Idell S, Koenig KB, Fair DS, Martin TR, McLarty J, Maunder RJ (1991) Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome. Am J Physiol 261:L240-L248
Ikegami M, Agata Y, Elkady T, Hallman M, Berry D, Jobe A (1987) Comparison of four surfactants: in vitro surface properties and responses of preterm lambs to treatment at birth. Pediatrics 79:39–46
Ikegami M, Jobe AH, Tabor BL, Rider ED, Lewis JF (1992) Lung albumin recovery in surfactant-treated preterm ventilated lambs. Am Rev Respir Dis 145:1005–1008
Iwaarden JF van, Welmers B, Verhoef J, Haagsman HP, Golde LMG van (1990) Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. Am J Respir Cell Mol Biol 2:91–98
Iwaarden JF van Strijp JAG van, Erbskamp MJM, Welmers AC, Verhoef J, Golde LMG van (1991) Surfactant protein A is opsonin in phagocytosis of herpes simplex virus type 1 by rat alveolar macrophages. Am J Physiol 261:L204-L209
Iwaarden JF van, Shimizu H, Golde PHM van, Voelker DR, Golde LMG van (1992) Rat surfactant protein D enhances the production of oxygen radicals by rat alveolar macrophages. Biochem J 286:5–8
Jackson LK (1982) Idiopathic pulmonary fibrosis. Clin Chest Med 3:579–592
Jefferies AL, Coates G, O'Brodovich H (1984) Pulmonary epithelial permeability in hyaline-membrane disease. N Engl J Med 311:1075–1080
Joka T, Obertacke U (1989) Neue medikamentöse Behandlung im ARDS: Effekt einer intrabronchialen xenogenen Surfactantapplikation. Z Herz- Thorax- Gefäßchirurgie 3 [Supp1]:21–24
Kaneko T, Sato T, Katsuya H, Miyauchi Y (1990) Surfactant therapy for pulmonary edema due to intratracheally injected bile acid. Crit Care Med 18:77–83
King RJ, MacBeth MC (1981) Interaction of the lipid and protein components of pulmonary surfactant. Role of phosphatidylglycerol and calcium. Biochim Biophys Acta 647:159–168
Kobayashi T, Ganzuka M, Taniguchi J, Nitta K, Murakami S (1990) Lung lavage and surfactant replacement for hydrochloric acid aspiration in rabbits. Acta Anaesthesiol Scand 34:216–221
Kobayashi T, Nitta K, Ganzuka M, Inui S, Grossmann G, Robertson B (1991) Inactivation of exogenous surfactant by pulmonary edema fluid. Pediatr Res 29:353–356
Kuroki Y, Mason R, Voelker D (1988) Pulmonary surfactant apoprotein A structure and modulation of surfactant secretion by rat alveolar type II cells. J Biol Chem 263:3388–3394
Lamm WJE, Albert RK (1990) Surfactant replacement improves lung recoil in rabbit lungs after acid aspiration. Am Rev Respir Dis 142:1279–1283
Lee CT, Fein AM, Lippmann M, Holtzman H, Kimbel P, Weinbaum G (1981) Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory distress syndrome. N Engl J Med 304:192–196
Lewis JF, Ikegami M, Higuchi R, Jobe A, Absolom D (1991) Nebulized vs. instilled exogenous surfactant in an adult injury model. J Appl Physiol 71:1270–1276
Lewis JF, Ikegami M, Jobe AH (1992) Metabolism of exogenously administered surfactant in the acutely injured lungs of adult rabbits. Am Rev Respir Dis 145:19–23
Nakstadt B, Boye NP, Lyberg T (1987) Procoagulant activities in human alveolar macrophages. Eur J Respir Dis 71:459–471
Nakstad B, Lydberg T, Skjonsberg OH, Boye NP (1990) Local activation of the coagulation and fibrinolysis systems in lung disease. Thromb Res 57:827–838
Nieman GF, Bredenberg CE (1985) High surface tension pulmonary edema induced by detergent aerosol. J Appl Physiol 58:129–136
Nieman GF, Goyette D, Paskanik A, Brendenberg C (1990) Surfactant displacement by plasma lavage results in pulmonary edema. Surgery 107:677–683
Notter RH, Shaprio DL, Ohning B, Whitsett JA (1987) Biophysical activity of synthetic phospholipids combined with purified lung surfactant 6000 dalton apoprotein. Chem Phys Lipids 44:1–17
O'Brodovich HM, Weitz JI, Possmayer F (1990) Effect of fibrinogen degradation products and lung ground substance on surface function. Biol Neonate 57:325–333
Persson A, Chang D, Rust K, Moxley M, Longmore W, Crouch E (1989) Purification and biochemical characterization of CP4 (SP-D), a collagenous surfactant-associated protein. Biochemistry 28:6361–6367
Petty TL, Silvers GW, Paul GW, Stanford RE (1979) Abnormalities in lung elastic properties and surfactant function in adult respiratory distress syndrome. Chest 75:571–574
Pison U, Seeger W, Buchhorn R, Joka T, Brand M, Obertacke U, Neuhof H, Schmit-Neuerburg KP (1989) Surfactant abnormalities in patients with respiratory failure after multiple trauma. Am Rev Respir Dis 140:1033–1039
Pison U, Tam EK, Caughey GH, Hawgood S (1989) Proteolytic inactivation of dog lung surfactant-associated proteins by neutrophil elastase. Biochim Biophys Acta 992:251–257
Pison U, Obertacke U, Seeger W, Hawgood S (1992) Surfactant protein A (SP-A) is decreased in acute parenchymal lung injury associated with polytrauma. Eur J Clin Invest
Possmayer F (1988) A proposed nomenclature for pulmonary surfactant-associated proteins. Am Rev Respir Dis 138:990–996
Pratt P (1977) The lung: structure, function, and disease. Williams and Wilkins, Baltimore, pp 45–57
Revak SD, Merritt TA, Hallman M, Cochrane CG (1986) Reconstitution of surfactant activity using purified human apoprotein and phospholipid measured in vitro and in vivo. Am Rev Respir Dis 134:1258–1265
Revak SD, Merritt TA, Degryse E, Stefani L, Courtney M, Hallman M, Cochrane CG (1988) Use of human surfactant low molecular apoproteins in the reconstitution of surfactant biologic activity. J Clin Invest 81:826–833
Reynolds HY (1989) Pulmonary host defenses — state of the art. Chest 95:223S–230S
Rice WR, Ross GF, Singleton FM, Dingle S, Whitsett JA (1987) Surfactant-associated protein inhibits phospholipid secretion from type II cells. J Appl Physiol 63:692–698
Richman PS, Spragg RG, Robertson B, Merritt TA, Curstedt T (1989) The adult respiratory distress syndrome: first trials with surfactant replacement. Eur Respir J 2 [Suppl 3]:109–111
Robertson B, Lachmann B (1988) Experimental evaluation of surfactants for replacement therapy. Exp Lung Res 14:279–310
Ross GF, Notter RH, Meuth J, Whitsett JA (1986) Phospholipid binding and biophysical activity of pulmonary surfactant-associated protein (SAP)-35 and its non-collagenous COOH-terminal domains. J Biol Chem 261:14283–14291
Rüfer R, Stolz C (1969) Inaktivierung von alveolären Oberflächenfilmen durch Erniedrigung der Oberflächen-spannung der Hypophase. Pflügers Arch 307:89–103
Ryan RM, Morris RE, Rice WR, Ciraolo G, Whitsett J (1989) Binding and uptake of pulmonary surfactant protein (SP-A) by pulmonary type II epithelial cells. J Histochem Cytochem 37:429–440
Ryan SF, Ghassibi Y, Liau DF (1990) Effects of activated polymorphonuclear leukocytes upon pulmonary surfactant in vitro. Am J Respir Cell Mol Biol 4:33–41
Seeger W, Lasch HG (1987) Septic lung. Rev Infect Dis 9:570–579
Seeger W, Suttorp N (1988) Role of membrane lipids in the pulmonary vascular abnormalities caused by bacterial toxins. Am Rev Respir Dis 136:462–466
Seeger W, Lepper H, Wolf HRD, Neuhof H (1985) Alteration of surfactant function after exposure to oxidative stress and to oxygenated and native arachidonic acid in vitro. Biochim Biophys Acta 835:58–67
Seeger W, Stöhr G, Wolf HRD, Neuhof H (1985) Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J Appl Physiol 58:326–338
Seeger W, Walmrath D, Menger M, Neuhof H (1986) Increased lung vascular permeability after arachidonic acid and hydrostatic challenge. J Appl Physiol 61:1781–1789
Seeger W, Hilbel J, Klapettek K, Pison U, Obertacke U, Joka T, Roka L (1991) Procoagulant activity in bronchoalveolar lavage of severly traumatized patients — relation to the development of acute respiratory distress. Throm Res 61:53–64
Seeger W, Thede C, Günther A, Grube C (1991) Surface properties and sensitivity to protein-inhibition of a recombinant apoprotein C-based phospholipid mixture in vitro — comparison to natural surfactant. Biochim Biophys Acta 1081:45–52
Seeger W, Günther A, Thede C (1992) Differential sensitivity to fibrinogen-inhibition of SP-C versus SP-B based surfactants. Am J Physiol 262:L285-L291
Shiffer K, Hawgood S, Düzgünes N, Goerke J (1988) Interactions of the low molecular weight group of surfactant-associated proteins (SP 5–18) with pulmonary surfactant lipids. Biochemistry 27:2689–2695
Speer CP, Götze B, Curstedt T, Robertson B (1991) Phagocytic functions and tumor necrosis factor secretion of human monocytes exposed to natural porcine surfactant (Curosurf). Pediatr Res 30:69–74
Spencer H (1977) In: Pathology of the lung, 3rd edn. Saunders, Philadelphia, pp 235–240
Strohmaier W, Redl H, Schlag G (1990) Studies of the potential role of a semisynthetic surfactant preparation in an experimental aspiration trauma in rabbits. Exp Lung Res 16:101–110
Suzuki Y, Fujita Y, Kogishi K (1989) Reconstitution of tubular myelin from synthetic lipids and proteins associated with pig pulmonary surfactant. Am Rev Respir Dis 140:75–81
Taylor FB, Abrams ME (1966) Effect of surface active lipoprotein on clotting and fibrinolysis, and of fibrinogen on surface tension of surface active lipoprotein. Am J Med 40:346–350
Termer AJ, Robinson SL, Borchelt J, Wright JR (1989) Human pulmonary surfactant protein (SP-A), a protein structurally homologous to C1q, can enhance FcR- and CR1-mediated phagocytosis. J Biol Chem 264:13923–13928
Tierney DF, Johnson RP (1965) Altered surface tension of lung extracts and lung mechanics. J Appl Physiol 20:1253–1260
van Daal GJ, So KL, Gommers D, Eijking EP, Fiévez RB, Sprenger MJ, van Dam DW, Lachman B (1991) Intratracheal surfactant administration restores gas exchange in experimental adult respiratory distress syndrome associated with viral pneumonia. Anesth Analg 72:589–595
van Daal GJ, Bos JAH, Eijking EP, Gommers D, Hannappel E, Lachmann B (1992) Surfactant replacement therapy improves pulmonary mechanics in end-stage influenza A pneumonia in mice. Am Rev Respir Dis 145:859–863
van Golde LMG, Batenburg JJ, Robertson B (1988) The pulmonary surfactant system: biochemical aspects and functional significance. Physiol Rev 68:374–455
Venkitaraman AR, Baatz JE, Whitsett JA, Hall SB, Notter RH (1991) Biophysical inhibition of synthetic phospholipid-lung surfactant apoprotein admixtures by plasma proteins. Chem Phys Lipids 57:49–57
Warr RG, Hawgood S, Buckley DI, Crisp TM, Schilling J, Benson BJ, Ballard PL, Clements JA, White RT (1987) Low molecular weight human pulmonary surfactant protein (SP5): isolation, characterization, and cDNA and amino acid sequences. Proc Natl Acad Sci USA 84:7915–7919
Whitsett JA, Ohning BL, Ross G, Meuth J, Weaver T, Holm BA, Shapiro DL, Notter RH (1986) Hydrophobic surfactant-associated protein in whole lung surfactant and its importance for biophysical activity in lung surfactant extracts used for replacement therapy. Pediatr Res 20:460–467
Wichert P von, Temmesfeld M, Meyer W (1981) Influence of septic shock upon phosphytidylcholine remodeling mechanism in rat lung. Biochim Biophys Acta 664:487–497
Williams MC, Hawgood S, Hamilton RL (1991) Changes in lipid structure produced by surfactant proteins SP-A, SP-B and SP-C. Am J Respir Cell Mol Biol 5:41–50
Wispé JR, Clark JC, Warner BB, Fajardo D, Hull WE, Holtzman RB, Whitsett JA (1990) Tumor necrosis factor-alpha inhibits expression of pulmonary surfactant protein. J Clin Invest 86:1954–1960
Yu SH, Possmayer F (1986) Reconstitution of surfactant activity by using the 6 kDa apoprotein associated with pulmonary surfactant. Biochem J 236:85–89
Yu SH, Possmayer F (1988) Comparative studies on the biophysical activities of the low-molecular-weight hydrophobic proteins purified from bovine pulmonary surfactant. Biochim Biophys Acta 961:337–350
Zelter M, Escudies BJ, Hoeffel JM, Murray JF (1990) Effects of aerosolized artificial surfactant on repeated oleic acid injury in sheep. Am Rev Respir Dis 141:1014–1019
Günther A, Bleyl H, Seeger W (1992) Apoprotein-based synthetic surfactants inhibit plasmic cleavage of fibrinogen in vitro. (submitted)
Seeger W, Elssner A, Giinther A, Krämer HJ, Kalinowski HO (1992) Lung surfactant phospholipids associate with polymerizing fibrin - loss of surface activity. (submitted)
Author information
Authors and Affiliations
Additional information
Dedicated to Prof. Dr. N. Zöllner on the occasion of his 70th birthday
Rights and permissions
About this article
Cite this article
Seeger, W., Günther, A., Walmrath, H.D. et al. Alveolar surfactant and adult respiratory distress syndrome. Clin Investig 71, 177–190 (1993). https://doi.org/10.1007/BF00180100
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00180100